China-developed AIDS Drug Estimated to be Priced at 2,500 Yuan

Home>>Business

Last updated at: (Beijing Time) Monday, March 31, 2003

China-developed AIDS Drug Estimated to be Priced at 2,500 Yuan

China's domestically-developed AIDS drug, zidovudine or AZT, is expected to be priced at 2,540 yuan, or 300 US dollars, per patient per year.

DISCUSSION

CHINESE

SEND TO FRIEND

China's domestically-developed AIDS drug, zidovudine or AZT, is expected to be priced at 2,540 yuan, or 300 US dollars, per patient per year.

Sources from the State Drug Administration of China say the price is an estimate provided by domestic drug manufacturers, and has yet to be approved by the country's price administration bureau.

The sources say China will also increase the range of AIDS drugs available on the market, and allow more domestic manufacturers to produce such drugs.

China's first batch of AZT was manufactured by Shanghai Desano BioPharmaceutical Co. and Northeast General Pharmaceutical Factory.

Questions?Comments? Click here

Restrictions Remain on AIDS Cure Tests: Official

China to Begin AIDS, Drug Education in Schools

China Puts New Anti-AIDS Drug in Clinical Use

Authenticity of Reports Shadowed by Smoke of Gun Powder ( 4 Messages)

China's Z11 Helicopters Get Green Light for Civilian Use ( 20 Messages)

US Publications Make Illegal Debut in China ( 2 Messages)

Kuwait City Struck by a Missile from Unknown Origin ( 4 Messages)

When Will the Humanitarian Disasters End? ( 19 Messages)